Not applicableStudy completedNCT00339859What this trial is testingDNA Repair, p53 and Apoptosis Phenotypes in Lung CancerWho this might be right forLung Neoplasms National Cancer Institute (NCI) 5,625
Very early researchStudy completedNCT03832985What this trial is testingPediatric Reporting of Adult-Onset Genomic ResultsWho this might be right forHereditary Breast and Ovarian Cancer SyndromeLynch SyndromeFamilial Hypercholesterolemia Geisinger Clinic 162
Not applicableStudy completedNCT03460483What this trial is testingUniversal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized CareWho this might be right forEndometrial AdenocarcinomaEndometrial CarcinomaLynch Syndrome+1 more Ohio State University Comprehensive Cancer Center 1,001
Not applicableLooking for participantsNCT07450612What this trial is testingLiquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease DetectionWho this might be right forColorectal CancerAdenoma ColonAdenoma Colon Polyp+16 more San Raffaele University 1,200
Not applicableLooking for participantsNCT07498829What this trial is testingPopulation Based Germline Testing for Early Detection and Prevention of CancerWho this might be right forBreast Cancer RiskOvarian Cancer RiskCancer Gene Mutation Queen Mary University of London 6,000
Not applicableUnknownNCT01123694What this trial is testingXeroderma Pigmentosum Patient ExperiencesWho this might be right forXeroderma Pigmentosum Henry Ford Health System 15
Not applicableUnknownNCT04605523What this trial is testingNeurofilament Light- Chain in Ataxia TelangiectasiaWho this might be right forAtaxia Telangiectasia Johann Wolfgang Goethe University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03875313What this trial is testingStudy of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more Calithera Biosciences, Inc 33
Testing effectiveness (Phase 2)Looking for participantsNCT03538899What this trial is testingAutologous Gene Therapy for Artemis-Deficient SCIDWho this might be right forSevere Combined Immunodeficiency University of California, San Francisco 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 20
Not applicableStudy completedNCT01216930What this trial is testingMolecular Screening for Lynch Syndrome in Southern DenmarkWho this might be right forColorectal CancerLynch SyndromeHNPCC Vejle Hospital 2,000
Not applicableAvailableNCT07380165What this trial is testingExpanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)Who this might be right forAtaxia-Telangiectasia (A-T) IntraBio Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT03924401What this trial is testingAcute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantWho this might be right forGraft Versus Host Disease Emory University 30
Not applicableNot Yet RecruitingNCT07201012What this trial is testingDetermining the Prevalence of Muir-Torre Syndrome in Patients With Lynch SyndromeWho this might be right forBasal Cell Carcinoma of Skin, Site UnspecifiedEpidermoid CarcinomaLynch Syndrome+1 more Centre Hospitalier Universitaire de Nīmes 150
Not applicableUnknownNCT04865601What this trial is testingDNA Adductomics for Colorectal Cancer InvestigationWho this might be right forColorectal CancerFamilial Adenomatous PolyposisHereditary Non-polyposis Colon Cancer+1 more University of Copenhagen 60
Testing effectiveness (Phase 2)WithdrawnNCT04370795What this trial is testingMatched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and SirolimusWho this might be right forSevere Combined Immune Deficiency (SCID) National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT01052623What this trial is testingStatus of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)Who this might be right forAtaxia TelangiectasiaGrowth Failure Johann Wolfgang Goethe University Hospital 24
Not applicableEnded earlyNCT00985413What this trial is testingObservational Study to Assess Natural History in Cockayne Syndrome PatientsWho this might be right forCockayne Syndrome DNage B.V. 40
Not applicableNot Yet RecruitingNCT06501417What this trial is testingEC_ItaLynch: Mainstreaming the Diagnosis of Lynch SyndromeWho this might be right forLynch SyndromeEndometrial Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Testing effectiveness (Phase 2)Ended earlyNCT02203513What this trial is testingA Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate CancerWho this might be right forOvarian CancerBreast CancerProstate Cancer National Cancer Institute (NCI) 111